Similar articles

• Immunology. A perfect mismatch.

  Kärre K. Kärre K. Science. 2002 Mar 15;295(5562):2029-31. doi: 10.1126/science.1070538. Science. 2002. PMID: 11896262 No abstract available.
• [Graft vs. host disease and graft vs. leukemia/tumor effect].

  Okamoto S. Okamoto S. Nihon Rinsho. 2003 Sep;61(9):1484-7. Nihon Rinsho. 2003. PMID: 14515713 Review. Japanese. No abstract available.
• The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.

  Bishara A, De Santis D, Witt CC, Brautbar C, Christiansen FT, Or R, Nagler A, Slavin S. Bishara A, et al. Tissue Antigens. 2004 Mar;63(3):204-11. doi: 10.1111/j.0001-2815.2004.00182.x. Tissue Antigens. 2004. PMID: 14989709
• Alloreactive killer cells: hindrance and help for haematopoietic transplants.

  Parham P, McQueen KL. Parham P, et al. Nat Rev Immunol. 2003 Feb;3(2):108-22. doi: 10.1038/nri999. Nat Rev Immunol. 2003. PMID: 12563295 Review.
• Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.

  Zhao XY, Huang XJ, Liu KY, Xu LP, Liu DH. Zhao XY, et al. Eur J Haematol. 2007 Apr;78(4):338-46. doi: 10.1111/j.1600-0609.2007.00822.x. Eur J Haematol. 2007. PMID: 17378893